Alnylam Pharmaceuticals, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | — | -900.3% | -869.6% |
| FY2017 | 100.0% | -556.2% | -545.9% |
| FY2018 | 97.6% | -1,087.6% | -1,016.6% |
| FY2019 | 88.6% | -427.5% | -403.2% |
| FY2020 | 84.9% | -168.1% | -174.1% |
| FY2021 | 86.4% | -83.9% | -101.0% |
| FY2022 | 86.5% | -75.7% | -109.0% |
| FY2023 | 85.3% | -15.4% | -24.1% |
| FY2024 | 86.4% | -7.9% | -12.4% |
| FY2025 | 81.8% | 13.5% | 8.4% |